Determinants of intestinal permeability in healthy first-degree relatives of individuals with Crohn's disease

Inflammatory Bowel Diseases

Volumn 21, Issue 4, 2015, Pages 879-887

  Kevans, David ^a,b   Turpin, Williams ^a   Madsen, Karen ^c   Meddings, Jon ^d   Shestopaloff, Konstantin ^e   Xu, Wei ^e   Moreno Hagelsieb, Gabriel ^f   Griffiths, Anne ^g   Silverberg, Mark S ^a,b   Paterson, Andrew ^h   Croitoru, Kenneth ^a,b  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

^d UNIVERSITY OF CALGARY   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

^f UNIVERSITY OF WATERLOO   (Canada)

^g HOSPITAL FOR SICK CHILDREN   (Canada)

^h HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

Author keywords

genetics; inflammatory bowel disease; intestinal permeability; microbiota

Indexed keywords

BACTERIAL DNA; GENOMIC DNA; LACTULOSE; MANNITOL; RNA 16S; TAP WATER;

ADOLESCENT; ADULT; ARTICLE; ASSAY; CHILD; CROHN DISEASE; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; FAMILY STUDY; FECES MICROFLORA; FEMALE; GENOTYPE; HERITABILITY; HUMAN; INFLAMMATORY BOWEL DISEASE; INTESTINE MUCOSA PERMEABILITY; MAJOR CLINICAL STUDY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRESCHOOL CHILD; PRIORITY JOURNAL; PYROSEQUENCING; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; YOUNG ADULT; ADVERSE EFFECTS; AGE; CLINICAL TRIAL; FAMILY; FECES; GENETIC PREDISPOSITION; GENETICS; GENOTYPE ENVIRONMENT INTERACTION; INTESTINE; METABOLISM; MICROBIOLOGY; MICROFLORA; MULTICENTER STUDY; PATHOPHYSIOLOGY; PERMEABILITY; SEX DIFFERENCE;

ADOLESCENT; ADULT; AGE FACTORS; CHILD; CROHN DISEASE; FAMILY; FECES; FEMALE; GENE-ENVIRONMENT INTERACTION; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTESTINES; LACTULOSE; MALE; MANNITOL; MICROBIOTA; PERMEABILITY; POLYMORPHISM, SINGLE NUCLEOTIDE; RNA, RIBOSOMAL, 16S; SEX FACTORS; SMOKING; YOUNG ADULT;

EID: 84925427704     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/MIB.0000000000000323     Document Type: Article

References (43)

1. Bernstein CN, Wajda A, Svenson LW, et al. The epidemiology of inflammatory bowel disease in Canada. A population-based study. Am J Gastroenterol. 2006;101:1559-1568.
2. Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology. 2004; 126:1504-1517.
3. Teshima CW, Meddings JB. The measurement and clinical significance of intestinal permeability. Curr Gastroenterol Rep. 2008;10:443-449.
4. Buhner S, Buning C, Genschel J, et al. Genetic basis for increased intestinal permeability in families with Crohn's disease: role of CARD15 3020insC mutation? Gut. 2006;55:342-347.
5. D'Inca R, Annese V, di Leo V, et al. Increased intestinal permeability and NOD2 variants in familial and sporadic Crohn's disease. Aliment Pharmacol Ther. 2006;23:1455-1461.
6. Fries W, Renda MC, Lo Presti MA, et al. Intestinal permeability and genetic determinants in patients, first-degree relatives, and controls in a high-incidence area of Crohn's disease in Southern Italy. Am J Gastroenterol. 2005;100:2730-2736.
7. Soderholm JD, Olaison G, Lindberg E, et al. Different intestinal permeability patterns in relatives and spouses of patients with Crohn's disease. An inherited defect in mucosal defence? Gut. 1999;44:96-100.
8. Zamora SA, Hilsden RJ, Meddings JB, et al. Intestinal permeability before and after ibuprofen in families of children with Crohn's disease. Can J Gastroenterol. 2013;13:31-36.
9. Peeters M, Geypens B, Claus D, et al. Clustering of increased small intestinal permeability in families with Crohn's disease. Gastroenterology. 1997; 113:802-807.
10. Hilsden RJ, Meddings JB, Sutherland LR. Intestinal permeability changes in response to acetylsalicylic acid in relatives of patients with Crohn's disease. Gastroenterology. 1996;110:1395-1403.
11. Munkholm P, Langholz E, Hollander D, et al. Intestinal permeability in patients with Crohn's disease and ulcerative colitis and their first degree relatives. Gut. 1994;35:68-72.
12. Marshall JK, Thabane M, Garg AX, et al. Intestinal permeability in patients with irritable bowel syndrome after a waterborne outbreak of acute gastroenteritis in Walkerton, Ontario. Aliment Pharmacol Ther. 2004;20:1317-1322.
13. Meddings JB. Review Article: Intestinal permeability in Crohn's disease. Aliment Pharmacol Ther. 1997;11(suppl 3):47-53.
14. Purcell S, Neale B, Todd-Brown K, et al. PLINK. A tool set for wholegenome association and population-based linkage analyses. Am J Hum Genet. 2007;81:559-575.
15. Jostins L, Ripke S, Weersma RK, et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature. 2012;491:119-124.
16. Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucinerich repeat variants with susceptibility to Crohn's disease. Nature. 2001; 411:599-603.
17. Barrett JC, Hansoul S, Nicolae DL, et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet. 2008;40:955-962.
18. Franke A, McGovern DP, Barrett JC, et al. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet. 2010;42:1118-1125.
19. Fisher SA, Tremelling M, Anderson CA, et al. Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn's disease. Nat Genet. 2008;40:710-712.
20. Stoll M, Corneliussen B, Costello CM, et al. Genetic variation in DLG5 is associated with inflammatory bowel disease. Nat Genet. 2004; 36:476-480.
21. Muise AM, Walters T, Wine E, et al. Protein-tyrosine phosphatase sigma is associated with ulcerative colitis. Curr Biol. 2007;17:1212-1218.
22. Muise AM, Walters TD, Glowacka WK, et al. Polymorphisms in E-cadherin (CDH1) result in a mis-localised cytoplasmic protein that is associated with Crohn's disease. Gut. 2009;58:1121-1127.
23. Masella AP, Bartram AK, Truszkowski JM, et al. PANDAseq: paired-end assembler for illumina sequences. BMC Bioinformatics. 2012;13:31.
24. Caporaso JG, Kuczynski J, Stombaugh J, et al. QIIME allows analysis of highthroughput community sequencing data. Nat Methods. 2010;7:335-336.
25. Edgar RC. Search and clustering orders of magnitude faster than BLAST. Bioinformatics. 2010;26:2460-2461.
26. DeSantis TZ, Hugenholtz P, Larsen N, et al. Greengenes, a chimerachecked 16S rRNA gene database and workbench compatible with ARB. Appl Environ Microbiol. 2006;72:5069-5072.
27. Breslin NP, Nash C, Hilsden RJ, et al. Intestinal permeability is increased in a proportion of spouses of patients with Crohn's disease. Am J Gastroenterol. 2001;96:2934-2938.
28. Li J, Ji L. Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix. Heredity (Edinb). 2005;95:221-227.
29. Hollander D, Vadheim CM, Brettholz E, et al. Increased intestinal permeability in patients with Crohn's disease and their relatives. A possible etiologic factor. Ann Intern Med. 1986;105:883-885.
30. May GR, Sutherland LR, Meddings JB. Is small intestinal permeability really increased in relatives of patients with Crohn's disease?. Gastroenterology. 1993;104:1627-1632.
31. Fries W, Belvedere A, Vetrano S. Sealing the broken barrier in IBD: Intestinal permeability, epithelial cells and junctions. Curr Drug Targets. 2013;14:1460-1470.
32. Secondulfo M, de Magistris L, Fiandra R, et al. Intestinal permeability in Crohn's disease patients and their first degree relatives. Dig Liver Dis. 2001;33:680-685.
33. Khor B, Gardet A, Xavier RJ. Genetics and pathogenesis of inflammatory bowel disease. Nature. 2011;474:307-317.
34. Carlsson AH, Yakymenko O, Olivier I, et al. Faecalibacterium prausnitzii supernatant improves intestinal barrier function in mice DSS colitis. Scand J Gastroenterol. 2013;48:1136-1144.
35. Chen TL, Chen S, Wu HW, et al. Persistent gut barrier damage and commensal bacterial influx following eradication of Giardia infection in mice. Gut Pathog. 2013;5:26.
36. Frazier TH, DiBaise JK, McClain CJ. Gut microbiota, intestinal permeability, obesity-induced inflammation, and liver injury. JPEN J Parenter Enteral Nutr. 2011;35:14S-20S.
37. Zoetendal EG, Raes J, van den Bogert B, et al. The human small intestinal microbiota is driven by rapid uptake and conversion of simple carbohydrates. ISME J. 2012;6:1415-1426.
38. Saltzman JR, Kowdley KV, Perrone G, et al. Changes in small-intestine permeability with aging. J Am Geriatr Soc. 1995;43:160-164.
39. Zamora SA, Hilsden RJ, Meddings JB, et al. Intestinal permeability before and after ibuprofen in families of children with Crohn's disease. Can J Gastroenterol. 1999;13:31-36.
40. Bjarnason I, Peters TJ, Wise RJ. The leaky gut of alcoholism: possible route of entry for toxic compounds. Lancet. 1984;1:179-182.
41. Prytz H, Benoni C, Tagesson C. Does smoking tighten the gut? Scand J Gastroenterol. 1989;24:1084-1088.
42. Suenaert P, Bulteel V, Den Hond E, et al. The effects of smoking and indomethacin on small intestinal permeability. Aliment Pharmacol Ther. 2000;14:819-822.
43. Andre C, Andre F, Colin L, et al. Measurement of intestinal permeability to mannitol and lactulose as a means of diagnosing food allergy and evaluating therapeutic effectiveness of disodium cromoglycate. Ann Allergy. 1987;59:127-130.